Pancreatic Cancer Research

ResearcherThe University of Texas at San Antonio Health Science CenterActive in the last 2 years

Sajid Ullah Khan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-1331-8846; OpenAlex author ID A5049748617. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 4

  1. The Combination of a BCL-xL PROTAC and an mTOR Inhibitor Sensitizes Pancreatic Ductal Adenocarcinoma to KRAS G12D Inhibitor Treatment. Last author DOI 10.3390/cancers18060920↗
  2. Targeting DDR2 for Treating Pancreatic Cancer. Co-author DOI 10.1158/1535-7163.mct-24-1226↗
  3. Targeting KRAS in pancreatic cancer: Emerging therapeutic strategies. Co-author DOI 10.1016/bs.acr.2023.02.004↗
  4. Overcoming Gemcitabine Resistance in Pancreatic Cancer Using the BCL-XL-Specific Degrader DT2216. First author DOI 10.1158/1535-7163.mct-21-0474↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Daohong Zhou · 4 shared papers, 2022–2026 · strength 0.92
  2. Guangrong Zheng · 2 shared papers, 2022–2026 · strength 0.42
  3. Javed Miyan · 1 shared paper, 2026 · strength 0.30
  4. Vignesh Vudatha · 1 shared paper, 2026 · strength 0.30
  5. Chris T.P. Do · 1 shared paper, 2025 · strength 0.19
  6. Manjeet K. Rao · 1 shared paper, 2025 · strength 0.19
  7. Deepika Singh · 1 shared paper, 2025 · strength 0.19
  8. Pei Wang · 1 shared paper, 2025 · strength 0.19
  9. Dinesh Thummuri · 1 shared paper, 2022 · strength 0.12
  10. Patrick W. Underwood · 1 shared paper, 2022 · strength 0.12
  11. Andrea N. Riner · 1 shared paper, 2022 · strength 0.12
  12. Jose Gilberto Trevino · 1 shared paper, 2022 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.